当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 2019年第1期
编号:13261156
MEG8-DMR对人肝癌Huh7细胞DLK1表达水平的影响(3)
http://www.100md.com 2019年1月5日 《中西医结合心血管病电子杂志》 2019年第1期
     参考文献

    [1] Barlow D P.Genomic Imprinting:A Mammalian Epigenetic Discovery Model[J].Annual Review of Genetics,2011,45(1):379-403.

    [2] Court F,Tayama C,Romanelli V,et al.Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment.[J].Genome Res.2014,24(4):554-569.

    [3] Donsante A,Miller D G,Li Y,et al.AAV vector integration sites in mouse hepatocellular carcinoma[J].Science,2007,317(5837):477.

    [4] Dupuy A J,Rogers L M,Kim J,et al.A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice.[J].Cancer Research,2009,69(20):8150-8156.

    [5] Lin S P,Youngson N,Takada S,et al.Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12[J].Nature Genetics,2003,35(1):97-102.

    [6] 鄭武,谷峰.CRISPR/Cas9的应用及脱靶效应研究进展[J].遗传,2015(10):1003-1010.

    [7] Jelinic P,Shaw P.Loss of imprinting and cancer[J].Journal of Pathology,2007,211(3):261.

    本文编辑:刘欣悦, 百拇医药(史啸坤 楚晨)
上一页1 2 3